Adenoid Vegetations in Adult Patients

Sponsor

Varazdin General Hospital (Other)

Overall Status

Recruiting

CT.gov ID

NCT06041074

Collaborator

(none)

150

Enrollment

Location

3.5

Anticipated Duration (Months)

42.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In this observational cross-sectional study " the clinical characteristics of adenoid vegetations in adulthood will be investigated.

Condition or Disease	Intervention/Treatment	Phase
Adenoid Vegetation

Detailed Description

Adenoid vegetations typically appear in childhood and are well described in this population. However, in adulthood, adenoid vegetations appear rarely and their characteristics have not been described.

The clinical characteristics of adenoid vegetations in adulthood will be investigated, and compared with clinical characteristics of adenoid vegetations in childhood.

Study Design

Study Type:

Observational

Anticipated Enrollment :

150 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

The Clinical Characteristics of Adenoid Vegetations in Adult Patients

Actual Study Start Date :

Sep 15, 2023

Anticipated Primary Completion Date :

Dec 31, 2023

Anticipated Study Completion Date :

Dec 31, 2023

Arms and Interventions

Arm	Intervention/Treatment
Adults Patients with adenoid vegetations, 14 years old and older
Children Patients with adenoid vegetations, 13 years old and younger

Outcome Measures

Primary Outcome Measures

Symptoms [2 months]
The leading symptom (patient's main complaint, the reason for seeing the doctor) will we recorded for each participant

Secondary Outcome Measures

Duration of symptoms [2 months]
The duration of leading symptom (in months) will be recorded for each participant
OTS (otoscopic) [2 months]
The otoscopic findings will be recorded in both groups
RNS (rhinoscopic) [2 months]
The rhinoscopic findings will be recorded in both groups
OFS (oropharyngoscopic) [2 months]
The oropharyngoscopic findings will be recorded in both groups
PRNS (post-rhynoscopic) [2 months]
The post-rhynoscopic findings will be recorded in both groups
Referring physician [2 months]
The physician (primary or secondary level) who referred the patient to ENT (Ear Nose and Throat doctor) will be recorded in both groups
PHD ( pathohistological findings) [2 months]
The pathohistological findings will be recorded in both groups
Surgery [2 months]
The type of surgery will be recorded in both groups
Outcome [2 months]
The outcome (the relief of the leading symptom) will be recorded in both groups
Recurrence [2 months]
The recurrence will be recorded in both groups

Eligibility Criteria

Criteria

Ages Eligible for Study:

1 Year to 105 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

patient with adenoid vegetations

Exclusion Criteria:

other concomitant otorhinolaryngological diagnoses
hypertrophy of the tonsils
oropharyngeal carcinomas
chronic sinuitis
allergic rhinitis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Varazdin General Hospital	Varazdin		Croatia	42000

Sponsors and Collaborators

Varazdin General Hospital

Investigators

Principal Investigator: Drazen Shejbal, Varazdin General Hospital, Varazdin, Croatia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Varazdin General Hospital

ClinicalTrials.gov Identifier:

NCT06041074

Other Study ID Numbers:

1968

First Posted:

Sep 18, 2023

Last Update Posted:

Sep 21, 2023

Last Verified:

Sep 1, 2023

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Sep 21, 2023